p53 as a significant prognostic marker in endometrial carcinoma

被引：0
作者：
Quddus, MR
Zheng, W
Sung, CJ
Lauchlan, SC
Felix, JC
机构：
[1] Brown Univ, Women & Infants Hosp, Dept Pathol, Providence, RI USA
[2] Univ So Calif, Womens & Childrens Hosp, Los Angeles, CA 90089 USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：112A / 112A
页数：1
相关论文
共 50 条
  • [21] Progesteron receptor status is a prognostic molecular marker in patients with P53 abnormal endometrioid endometrial cancer
    Omatsu, Kohei
    Chang, Ting-Chang
    Jung, Shih-Ming
    Ueng, Shir-Hwa
    Chang, Wei-Yan
    Lynn, Perera
    Chen, Shu-Shen
    Chou, Hung-Hseh
    Lai, Chyong-Huey
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A160 - A161
  • [22] P53 expression in adenomyosis in endometrial carcinoma patients
    Taskin, M
    Lallas, TA
    Shevchuk, M
    Barber, HRK
    GYNECOLOGIC ONCOLOGY, 1996, 62 (02) : 241 - 246
  • [23] THE PROGNOSTIC-SIGNIFICANCE OF K-RAS ACTIVATION AND P53 OVEREXPRESSION IN ENDOMETRIAL CARCINOMA
    BURKS, RT
    NASIM, SN
    KORNSTEIN, MJ
    PODCZASKY, E
    ZAINO, RJ
    GARRETT, CT
    LABORATORY INVESTIGATION, 1995, 72 (01) : A86 - A86
  • [24] P53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma
    Powell, B
    Soong, R
    Grieu, F
    Knowles, S
    Hammond, I
    Iacopetta, B
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 14 (01) : 175 - 179
  • [25] PROGNOSTIC-SIGNIFICANCE OF P53 OVEREXPRESSION IN ENDOMETRIAL CANCER
    ITO, K
    WATANABE, K
    NASIM, S
    SASANO, H
    SATO, S
    YAJIMA, A
    SILVERBERG, SG
    GARRETT, CT
    CANCER RESEARCH, 1994, 54 (17) : 4667 - 4670
  • [26] P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection
    Qin, LX
    Tang, ZY
    Ma, ZC
    Wu, ZQ
    Zhou, XD
    Ye, QH
    Ji, Y
    Huang, LW
    Jia, HL
    Sun, HC
    Wang, L
    WORLD JOURNAL OF GASTROENTEROLOGY, 2002, 8 (03) : 459 - 463
  • [27] Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?
    Masuda, Akinori
    Kamai, Takao
    Abe, Hideyuki
    Arai, Kyoko
    Yoshida, Ken-Ichiro
    BIOMEDICAL RESEARCH-TOKYO, 2009, 30 (03): : 171 - 176
  • [28] P53 immunohistochemical scoring:an independent prognostic marker for patients after hepatocellular carcinoma resection
    Lun-Xiu Qin Zhao-You Tang Zeng-Chen Ma Zhi-Quan Wu Xin-Da Zhou Qing-Hai Ye Yuan Ji Li-Wen Huang Hu-Liang Jia Hui-Chuan Sun Lu Wang
    World Journal of Gastroenterology, 2002, 8 (03) : 459 - 463
  • [29] p53 gene abnormalities and p53 protein accumulation as prognostic indicators in colorectal carcinoma
    Leahy, DT
    Salman, R
    Mulcahy, H
    Sheahan, K
    ODonoghue, DP
    Parfrey, NA
    LABORATORY INVESTIGATION, 1996, 74 (01) : 341 - 341
  • [30] p53 expression as a prognostic marker in inflammatory breast cancer
    Gonzalez-Angulo, AM
    Sneige, N
    Buzdar, AU
    Valero, V
    Kau, SW
    Broglio, K
    Yamamura, Y
    Hortobagyi, GN
    Cristofanilli, M
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6215 - 6221
12345